Chest CT, stress testing find PE in 25% of COVID-19 patients
A quarter of patients hospitalized with COVID-19 show pulmonary embolism (PE...Read more on AuntMinnie.comRelated Reading: Reduced-dose CT effective for lung nodules in kids Through COVID-19 pandemic, CT has shown high diagnostic accuracy Researchers report on PET/CT's COVID-19 pandemic performance AI-based program helps follow up incidental lung nodules on CT Deep-learning algorithm estimates cancer risk of pulmonary nodules (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 13, 2021 Category: Radiology Source Type: news

Improving the care of patients discharged following a pulmonary embolism, in line with NICE Guidelines [NG158]
Project started out as audit looking into how to improve discharge process for patients following a PE, however upon understanding limitations of care provided on discharge, practice was changed in line with NICE guidelines to ensure safest possible discharge for these patients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 2, 2021 Category: Consumer Health News Source Type: news

Bile pulmonary embolism-related sudden death following an abdominal firearm injury: an autopsy case report and review of literature - Fnon NF, Seleim HM, Abdel-Wahab MS, Sobh ZK.
This article reports a fa... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Aidoc and Icometrix pair up for stroke care
Artificial intelligence (AI) software developer Aidoc has joined forces wit...Read more on AuntMinnie.comRelated Reading: Radiology Partners joins forces with Aidoc Aidoc unveils AI notification application for PE Icometrix launches AI software for ischemic stroke Aidoc and Imbio team up on AI for pulmonary embolism Icometrix names new chief commercial officer Icometrix nets FDA OK for epilepsy detection software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2021 Category: Radiology Source Type: news

What Is the Survival Rate of a Pulmonary Embolism
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

Postop chylothorax treated with intranodal lymphangiography, ethiodized oil
(American Roentgen Ray Society) According to AJR, high-dose intranodal lymphangiography with ethiodized oil is a safe and effective procedure for treating high-output postsurgical chylothorax with chest tube removal in 83% of patients. Previously, no data were available on the safety or benefits of injecting higher doses of ethiodized oil to treat patients with refractory postoperative chylothorax. No early or late clinically relevant complications, including symptomatic pulmonary or paradoxical embolism, were recorded for any of the patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

Are ventilation scans needed in pulmonary embolism assessments?
Are ventilation nuclear medicine lung scans really needed in cases of suspecte...Read more on AuntMinnie.comRelated Reading: SNMMI pushes for coverage of PET tracers for Aduhelm use SNMMI issues new guidelines on V/Q scans SNMMI urges fast-track review of Technegas for V/Q scans SNMMI updates ventilation study guidance SNMMI 2020: How nuclear medicine handled COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2021 Category: Radiology Source Type: news

Home treatment cost saving in stable patients with pulmonary embolism
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

SIIM, RSNA, others partner on COVID-19 AI challenge
A machine-learning challenge to promote the development of algorithms for th...Read more on AuntMinnie.comRelated Reading: MIDRC offers support for COVID-19 AI AMVC Spring 2021: MIDRC project targets AI challenges of COVID-19 Imaging groups take stand against AI deregulation RSNA announces pulmonary embolism challenge winners C-MIMI: Use of AI in radiology is evolving (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 18, 2021 Category: Radiology Source Type: news

Latest Trends in the Management of Pulmonary Embolism Latest Trends in the Management of Pulmonary Embolism
Following clinical management of cancer-associated VTE in the hospital, direct oral anticoagulant therapy at discharge is your starting point, except in cases of intact luminal cancers.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 11, 2021 Category: Intensive Care Tags: Hospital Medicine News Source Type: news

Management of Acute Pulmonary Embolism With a PE Response Team Management of Acute Pulmonary Embolism With a PE Response Team
This article provides an overview of the PERT process, highlighting risk stratification and treatment.Journal of the American Board of Family Medicine (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 10, 2021 Category: Intensive Care Tags: Family Medicine/Primary Care Journal Article Source Type: news

Study finds up to 24 percent of esophagectomy patients can develop VTE post-operatively
(American Association for Thoracic Surgery) A new study presented today at the AATS 101st Annual Meeting, found that the percentage of patients undergoing esophagectomy for cancer who suffer Venous Thromboembolism (VTE) post-operatively is much higher than previously reported, with as many as 24 percent suffering from Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE). Six-month mortality for patients with VTE was 17.6 percent compared to 2.1 percent for those without. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision
NEW BRUNSWICK, N.J., April 23, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the Company’s COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization (EUA), following a decision from the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA).The decision was based on a recommendation from the U.S. CDC Advisory Committee on Immunization Practices (ACIP), which followed a rigorous evaluation of data relating to a very rare adverse event involving blood clots in combin...
Source: Johnson and Johnson - April 23, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) ReviewEMA Confirms Overall Benefit-Risk Profile Remains Positive
NEW BRUNSWICK, N.J., April 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of the Company’s COVID-19 vaccine and confirmed the overall benefit-risk profile remains positive. The guidance follows PRAC review of a small number of cases of a very rare adverse event involving blood clots in combination with low platelet counts that can occur within approximately one to three weeks following injection with the Company’s COVID-19 vaccine. As a resul...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Imbio signs Heart&Lung Health in U.K.
Artificial intelligence software developer Imbio has signed a deal with U.K...Read more on AuntMinnie.comRelated Reading: Imbio nets FDA nod for RV/LV Analysis AI algorithm Aidoc and Imbio team up on AI for pulmonary embolism Siemens adds Imbio AI apps to syngo.via platform Imbio teams up with Genentech for AI in lung disease Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Radiology Partners joins forces with Aidoc
Imaging services provider Radiology Partners and artificial intelligence (AI...Read more on AuntMinnie.comRelated Reading: Radiology Partners promotes 13 radiologists Aidoc unveils AI notification application for PE Radiology Partners completes Mednax deal 3 predictions for radiology AI in 2021 Aidoc and Imbio team up on AI for pulmonary embolism Radiology Partners sees scale as benefit of Mednax deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

High thrombotic risk in cancer patients receiving immunotherapy
(Medical University of Vienna) In a study recently published in the leading journal " Blood " , researchers at MedUni Vienna provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment. The main finding is that, during the course of treatment, approximately 13% of patients develop a venous thromboembolism, that is to say a deep vein thrombosis or pulmonary embolism, and approximately 2% develop a thrombosis in the arterial system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 31, 2021 Category: Cancer & Oncology Source Type: news

Imbio nets FDA nod for RV/LV Analysis AI algorithm
Artificial intelligence (AI) software developer Imbio has garnered U.S. Foo...Read more on AuntMinnie.comRelated Reading: Aidoc and Imbio team up on AI for pulmonary embolism New AI lab at UMass focuses on thoracic imaging Siemens adds Imbio AI apps to syngo.via platform Imbio teams up with Genentech for AI in lung disease Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news

Imbio Receives FDA 510(k) Clearance for New Cardiothoracic Imaging Algorithm
MINNEAPOLIS, March 16, 2021 -- (Healthcare Sales & Marketing Network) -- Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RV/LV ... Devices, Cardiology, Radiology, FDA Imbio, RV/LV Analysis, pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2021 Category: Pharmaceuticals Source Type: news

Why Countries Around the World Are Suspending Use of AstraZeneca ’s COVID-19 Vaccine
It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal. The European Medicines Agency, which oversees drugs and vaccines in Europe, is expected to issue a guidance on March 18 about whether the side effects were related to the vaccine after reviewing the reports; in the meantime, it says the benefits of ...
Source: TIME: Health - March 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Covid-19 vaccine safe, based on scientific evidence, AstraZeneca reassures the world
It further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with its vaccine has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Blood clot in arm: Five changes to your arms that could be symptoms of a blood clot
BLOOD clots are serious medical emergencies, and could lead to a dangerous pulmonary embolism if left untreated. But how are you supposed to know if you're at risk of a blood clot in your arm? These are the five symptoms in your arm to look out for, including subtle changes to the skin. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2021 Category: Consumer Health News Source Type: news

AstraZeneca says 'no evidence' of higher blood clots risk from vaccine
"An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country" from the jab, a company spokesperson said. (Source: The Economic Times)
Source: The Economic Times - March 12, 2021 Category: Consumer Health News Source Type: news

Aidoc unveils AI notification application for PE
Artificial intelligence (AI) software developer Aidoc has introduced an AI-base...Read more on AuntMinnie.comRelated Reading: 3 predictions for radiology AI in 2021 Aidoc and Imbio team up on AI for pulmonary embolism FDA clears Aidoc's incidental PE AI algorithm Aidoc secures European contract FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 2, 2021 Category: Radiology Source Type: news

Amal Mattu's Top Non-COVID Studies in 2020 Amal Mattu's Top Non-COVID Studies in 2020
Amal Mattu's picks include tips on treating gonococcal infection, the use of thrombolytics for acute ischemic stroke, and treating low-risk pulmonary embolism.Medscape Emergency Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2021 Category: Consumer Health News Tags: Emergency Medicine Viewpoint Source Type: news

Bluemke to step down as editor of Radiology
The RSNA is now accepting applications from candidates interested in becomin...Read more on AuntMinnie.comRelated Reading: Dr. Mary Mahoney becomes president of RSNA board RSNA awards Margulis prize to COVID-19 paper RSNA announces pulmonary embolism challenge winners Radiology experts list COVID-19 best practices Bluemke leaves NIH to head up Radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 11, 2021 Category: Radiology Source Type: news

Clinical Pearl: Pulmonary Cement Embolism
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - February 1, 2021 Category: Emergency Medicine Tags: Clinical Pearl Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe CO...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, wit...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Patient Care - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Administration and Leadership - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Latest News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS: Journal of Emergency Medical Services News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Operations - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Special Topics - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Bilateral Pulmonary Embolism While Receiving Tranexamic Acid Bilateral Pulmonary Embolism While Receiving Tranexamic Acid
This case of bilateral pulmonary embolism in a healthy, active middle-aged woman reinforces the possible increased risk of thromboembolism in patients receiving tranexamic acid.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism? Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism?
About 6% of patients with chronic obstructive pulmonary disease who are admitted to the hospital with worsening respiratory symptoms will have pulmonary embolism, new research from France suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 6, 2021 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Patient Care - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Administration and Leadership - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Latest News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS: Journal of Emergency Medical Services News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Operations - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Special Topics - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Assessment of neutrophil extracellular traps in coronary thrombus of case series of patients with COVID-19
(JAMA Network) Severe COVID-19 is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the blockage of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. This case series report of five patients sought to   determine the role of NETs in coronary thrombosis in patients with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 29, 2020 Category: Infectious Diseases Source Type: news

RSNA says 29K attended 2020 virtual meeting
Over 29,000 radiology professionals from 134 countries around the world attended...Read more on AuntMinnie.comRelated Reading: RSNA 2020 wrap-up: Missing the RSNA traditions Does RSNA 2020 measure up for vendors? RSNA awards Margulis prize to COVID-19 paper RSNA announces pulmonary embolism challenge winners How to work the virtual RSNA conference (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2020 Category: Radiology Source Type: news

Aidoc and Imbio team up on AI for pulmonary embolism
Artificial intelligence (AI) software developers Aidoc and Imbio have formed...Read more on AuntMinnie.comRelated Reading: New AI lab at UMass focuses on thoracic imaging Siemens adds Imbio AI apps to syngo.via platform FDA clears Aidoc's incidental PE AI algorithm Imbio teams up with Genentech for AI in lung disease Aidoc secures European contract FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2020 Category: Radiology Source Type: news

RSNA awards Margulis prize to COVID-19 paper
The RSNA has awarded its Alexander R. Margulis Award for Scientific Excellence...Read more on AuntMinnie.comRelated Reading: RSNA announces pulmonary embolism challenge winners RSNA names PE as 2020 AI challenge topic RSNA unveils plans for virtual technical exhibition RSNA addresses COVID-19 impact on private practice RSNA wins grant to develop learning center in Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2020 Category: Radiology Source Type: news

RSNA announces pulmonary embolism challenge winners
RSNA in collaboration with the Society for Thoracic Radiology (STR) has announced...Read more on AuntMinnie.comRelated Reading: COVID-19, AI, and dose reduction top RSNA's CT agenda How to work the virtual RSNA conference AI shows growing maturity in RSNA informatics sessions RSNA names PE as 2020 AI challenge topic ACR to develop COVID-19 imaging research registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2020 Category: Radiology Source Type: news

Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2020 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Pulmonology, Radiology, Journal, Source Type: news